hematology/ oncology grand roundsÂ
out of 21
Post on 12-Nov-2014
Embed Size (px)
- 1. Hematology/Oncology Grand Rounds September 3, 2004 Merkel Cell Carcinoma Presented by Coy Heldermon
- CC: Bleeding bottom
- HPI: 57yo WM fell in his backyard while getting off of a ladder and bruised his R buttock. Hematoma formed and over several days the skin broke down and he noticed bleeding. He presented to his PCP who cauterized the bleeding sites and took biopsies.
- PMH: prostatectomy
- mononucleosis as teen
- FH: Aunt Br Ca, Uncle Lung Ca
- SH: Married, 3 grown children, remote 14pyh of cigarettes, social ETOH use.
- ROS: Negative except pain and bleeding at R buttock
- PE: remarkable only for necrosis at 2cm hematoma site on mid R buttock
- Clinical Course
- June 02 pathology read as small cell neoplasm at an OSH and referred to BJH with final reading of Merkel cell carcinoma. Pt underwent local excision at R buttock with iliac lymph node dissection and spermatic cord excision.
- Surgical margins were positive and 3/3 lymph nodes had disease.
- CT chest, abdomen, pelvis demonstrated no evidence of metastatic disease.
- October 02 Pt. referred to BJH Oncology. Pt received 3 cycles vincristine/adriamycin/cytoxan followed by radiation therapy and concurrent cisplatin/etoposide.
- September 03 CT/PET reveals metastatic disease in the lungs, pancreas, L femoral neck, scapula, iliac and sacral lymph node chains, chest wall and a bone lesion at S4.
- Pt underwent 5 cycles of cisplatin/irinotecan.
- May 04 CT - Resolution of chest wall lesion and decreased size of remaining lesions.
- The patients therapy was only complicated by the expected periodic nausea and cytopenias with persistent anemia.
- 4. Merkel Cell
- So what is a Merkel cell?
- identified in 1875 by Friedrich Sigmund Merkel, President of University of Rostock, professor of anatomy & physician. Dr. Merkel identified the cell as a component of the touch receptor
- 5. Merkel Cell
- Nondendritic, nonkeratinocytic epidermal cell near the basal layer, usually directly associated with nerve terminals especially near hair follicles and sweat gland ridges.
- Some may be in the dermis but not associated with nerve cells.
- 6. Merkel Cell
- Slow adapting type I mechanoreceptor
- Contain dense core granules similar to neurosecretory granules.
- Thought to release glutamate (among other things) in response to mechanical stimulation.
- Likely of neural crest origin.
- Possibly not the cell of origin of Merkel cell carcinoma.
- 7. Merkel Cell Carcinoma
- 1 st described by Toker in 1972 as a trabecular cancer of the dermis with high lymphatic metastatic risk and found mainly in elderly patients. (Arch Dermatol 1972;105:107-110)
- U.S. Annual Incidence is ~0.4/100,000
- U.S. Median age is ~70 years
- 90% are found in caucasians, ~80% are in men.
- 80% are liver> lung> bones> brain
- 9. Merkel Cell Carcinoma
- CT to assess regional lymph node involvement.
- CXR to evaluate for lung metastases.
- Sentinel node biopsy to evaluate lymphatic extension and thus efficacy of local therapy.
- 10. Merkel Cell Carcinoma Pathology
- Pathology is of three types often in combination.
- Solid (50%) irregular nests of intermediate sized basophilic cells in dense fibrous connective tissue.
- Diffuse (42%)- small irregular hyperchromatic cells in diffusely infiltrating sheets.
- Trabecular (8%)- irregular cords or ribbons of basophilic cells.
- 11. Merkel Cell Carcinoma
- Tumor often is necrotic and preferentially invades vascular and perineural spaces.
- Invasion beyond the dermis is a predictor of metastases - 78% metastatic vs 29% metastatic in those with tumor confined to dermis.
- 12. Merkel Cell Carcinoma
- Cells typically have prominent ovoid nuclei, dispersed chromatin, sparse cytoplasm, conspicuous nucleoli, and multiple neurosecretory granules
- 13. Merkel Cell Carcinoma
- Histochemistry is positive for CK8, CK 18, CK20, somatostatin receptor, chromogranin A(from neuroendocrine granules), neuron specific enolase, & synaptophysin(from the pre-synaptic vesicles)
- CK7 and TTF-1(thyroid transcription factor) are negative, distinguishing MCC from SCLC
- 14. Merkel Cell Carcinoma CK 18 Stain CK20 Stain Int J Derm 42:669-676, 2003 J Clin Onc 20(2): 588-598, 2002
- 15. Merkel Cell Carcinoma Staging
- Two staging systems are commonly used, The AJCC system and the Yiengpruksawan system (used more often)
- Ys system is
- Stage I for no nodal dz
- Stage II for nodal disease
- Stage III for systemic metastases
- 16. Merkel Cell Carcinoma Treatment J Clin Onc 20(2): 588-598, 2002
- 17. Merkel Cell Carcinoma Treatment Options Int J Derm 42:669-676, 2003
- 18. Merkel Cell Carcinoma Treatment Options
- Other regimens in the literature include:
- cyclophosphamide, doxorubicin, vincristine
- cyclophosphamide, epirubicin, vincristine
- cyclophosphamide, doxorubicin, vincristine + prednisone
- cyclophosphamide, doxorubicin, vincristine alternating with cisplatin & etoposide
- doxorubicin, ifosfamide
- cisplatin +/- doxorubicin
- Cyclophosphamide, anthracyclines and cisplatin are the most commonly used drugs in the literature.
- Response rates for multidrug regimens are reported at 60-70%.
- 19. Merkel Cell Carcinoma Survival J Clin Onc 20(2): 588-598, 2002
- 20. Merkel Cell Carcinoma Future Directions
- Bcl-2 antisense
- 21. Bibliography
- Halata Z, Grim M, Bauman KI. Friedrich Sigmund Merkel and his "Merkel cell", morphology, development, and physiology: review and new results. Anat Rec. 2003 Mar;271A(1):225-39
- Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States.J Am Acad Dermatol 2003; 49:832-841
- Mendenhall WM, Mendenhall CM, Mendenhall NP. Merkel Cell Carcinoma. Laryngoscope 2004; 114:906-910
- Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126:1514-1519
- Mott RT, Smoller BR, Morgan MB. Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol 2004; 31:217-223
- Krasagakis K, Tosca AD. Overview of Merkel cell carcinoma and recent advances in research. Int J Derm 2003; 42:669-676
- Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Onc 2002; 20:588-598
- George TK, di Santagnese PA, Bennett JM. Chemotherapy for metastatic Merkel cell carcinoma. Cancer 1985; 56:1034-1038
- Tai PTH, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, Gilchrist J. Chemotherapy in Neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Onc 2000; 18:2493-2499
View more >